This trial tests a nurse-led intervention to help improve quality of life for people living with Alzheimer's and their caregivers, and to make them safer in the community.
- Alzheimer's Disease
- Mild Cognitive Impairment
18 Primary · 0 Secondary · Reporting Duration: at study completion, an average of 8 weeks
1 Treatment Group
1 of 1
60 Total Participants · 1 Treatment Group
Primary Treatment: SUPPORT-D Group · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there an ongoing opportunity to join this trial?
"As indicated on the clinicaltrials.gov platform, this medical trial is still recruiting patients and commenced in December of 2022; further updates were made to the study that same month." - Anonymous Online Contributor
What is the current tally of participants in this research endeavor?
"Affirmative, the details posted on clinicaltrials.gov indicate that this trial has begun recruiting participants. The initial posting was made December 1st 2022 and recently updated on the same day. 60 patients are required to be recruited from a single medical centre." - Anonymous Online Contributor